… Combination therapy with inhaled long-acting β2 agonist plus inhaled corticosteroid was
prescribed at the outpatient services of our chest division. He was admitted because of …

… The final diagnosis was not established in our patient until pancytopenia developed and
bone marrow examination was performed. The initial presentation of our patient was …

… pteronyssinus and cat were significant risk factors for asthma diagnosis in our subjects. …
Inhalant allergens as risk factors for the development and severity of mild-to-moderate asthma in …

… for inhaled corticosteroids using and the risk of cataracts is inconsistent until now. Glaucoma
is the major culprit of cause blindness, and inhaled corticosteroids … inhaled corticosteroids /…

… inhaled corticosteroids are not useful. Neither prophylactic nor inhaled corticosteroids are
… The ETAC trial enrolled children with atopic dermatitis (as a group at high risk of developing …

… , the latter being an independent risk factor for other complications … corticosteroids, this does
not always happen, and these patients require close monitoring due to the risk of developing …

… Therapeutic Chemical classification system, we developed the PBDI, a comorbidity … Mist™
Inhaler, tiotropium HandiHaler®, long-acting beta-2 agonists (LABA), inhaled corticosteroids (…

… Inhaled corticosteroids (ICS) has been considered the standard therapy for COPD. Whether
the … circumstances, COPD patients with ICS use had to keep the osteoporosis development. …

… risks regression models to assess the risks for mental disorders in patients with ACOS
receiving ICS. … Patients with ACOS using ICS had higher risk of developing mental disorders. …

… BPD with a high risk of death from respiratory failure " . Early inhaled corticosteroids do not
confer … Low plasma retinol concentrations increase the risk of developing bronchopulmonary …